Price T Rowe Associates Inc Eli Lilly & CO Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Price T Rowe Associates Inc holds 20,930,287 shares of LLY stock, worth $16.7 Billion. This represents 2.13% of its overall portfolio holdings.

Number of Shares
20,930,287
Previous 20,651,736 1.35%
Holding current value
$16.7 Billion
Previous $18.7 Billion 0.83%
% of portfolio
2.13%
Previous 2.24%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$772.14 - $960.02 $215 Million - $267 Million
278,551 Added 1.35%
20,930,287 $18.5 Billion
Q2 2024

Aug 14, 2024
BUY
$724.87 - $909.04 $28 Million - $35.2 Million
38,675 Added 0.19%
20,651,736 $18.7 Billion
Q1 2024

May 15, 2024
SELL
$592.2 - $792.28 $719 Million - $961 Million
-1,213,514 Reduced 5.56%
20,613,061 $16 Billion
Q4 2023

Feb 14, 2024
SELL
$525.19 - $619.13 $215 Million - $253 Million
-409,417 Reduced 1.84%
21,826,575 $12.7 Billion
Q3 2023

Nov 14, 2023
SELL
$434.7 - $599.3 $837 Million - $1.15 Billion
-1,924,967 Reduced 7.97%
22,235,992 $11.9 Billion
Q2 2023

Aug 14, 2023
BUY
$350.74 - $468.98 $504 Million - $674 Million
1,438,225 Added 6.33%
24,160,959 $11.3 Billion
Q1 2023

May 15, 2023
BUY
$310.63 - $364.82 $16.7 Million - $19.6 Million
53,744 Added 0.24%
22,722,734 $7.8 Billion
Q4 2022

Feb 14, 2023
SELL
$321.55 - $374.67 $698 Million - $813 Million
-2,170,332 Reduced 8.74%
22,668,990 $8.29 Billion
Q3 2022

Nov 14, 2022
BUY
$296.48 - $337.87 $1.31 Billion - $1.49 Billion
4,412,664 Added 21.6%
24,839,322 $8.05 Billion
Q2 2022

Aug 15, 2022
SELL
$278.73 - $327.27 $139 Million - $163 Million
-498,109 Reduced 2.38%
20,426,658 $6.62 Billion
Q1 2022

May 16, 2022
SELL
$234.69 - $291.66 $1 Billion - $1.24 Billion
-4,259,691 Reduced 16.91%
20,924,767 $5.99 Billion
Q4 2021

Feb 14, 2022
SELL
$224.85 - $279.04 $1.14 Billion - $1.42 Billion
-5,071,623 Reduced 16.76%
25,184,458 $6.96 Billion
Q3 2021

Nov 15, 2021
BUY
$221.6 - $272.71 $779 Million - $959 Million
3,516,865 Added 13.15%
30,256,081 $6.99 Billion
Q2 2021

Aug 16, 2021
BUY
$180.55 - $233.54 $105 Million - $136 Million
584,215 Added 2.23%
26,739,216 $6.14 Billion
Q1 2021

May 17, 2021
BUY
$164.32 - $212.72 $2.31 Billion - $2.99 Billion
14,060,388 Added 116.25%
26,155,001 $4.89 Billion
Q4 2020

Feb 16, 2021
BUY
$130.46 - $172.63 $1.58 Billion - $2.09 Billion
12,094,613 New
12,094,613 $2.04 Billion

Others Institutions Holding LLY

# of Institutions
4,011
Shares Held
751M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email